Rubicon Research Ltd Surges on Bullish Technical Momentum and Strong Market Returns
2026-06-03 08:07:28Rubicon Research Ltd has demonstrated a remarkable price momentum shift, supported by a strong technical upgrade and a significant surge in market performance. The pharmaceutical and biotechnology small-cap stock has been re-rated to a Strong Buy with a Mojo Score of 90.0, reflecting robust bullish signals across multiple technical indicators and a substantial outperformance relative to the Sensex.
Read full news articleRubicon Research Ltd Surges 9.95% to Day's High of Rs 1285.7 — Outperforms Sector by 10.56 Percentage Points
2026-06-02 14:17:16The Sensex gained a modest 0.75% on 2 Jun 2026, while Rubicon Research Ltd surged 9.95%, outperforming its Pharmaceuticals & Biotechnology sector by 10.56 percentage points. This sharp single-session advance, which pushed the stock to a new 52-week and all-time high of Rs 1285.7, signals a strong momentum continuation rather than a mere technical bounce.
Read full news articleRubicon Research Ltd is Rated Strong Buy
2026-06-02 10:10:51Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 June 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news articleRubicon Research Ltd Surges on High-Value Trading and Institutional Interest
2026-06-02 10:00:28Rubicon Research Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 2 June 2026, registering a robust 5.27% gain. The stock’s remarkable performance is underpinned by strong institutional participation, significant order flow, and a fresh 52-week high, signalling growing investor confidence amid a challenging market backdrop.
Read full news articleBroad-Based Technical Strength Lifts Rubicon Research Ltd to 52-Week High of Rs 1258.2
2026-06-02 09:54:40Surging to an all-time high of Rs 1258.2 on 2 Jun 2026, Rubicon Research Ltd has demonstrated remarkable price momentum, outpacing its sector and defying the broader market's subdued tone. This milestone caps a three-day rally that has delivered a 25.48% gain, underscoring the stock's robust technical backdrop amid a Sensex trading near its 52-week low.
Read full news articleBroad-Based Technical Strength Lifts Rubicon Research Ltd to 52-Week High of Rs 1258.2
2026-06-02 09:54:39With a decisive surge to Rs 1258.2 on 2 Jun 2026, Rubicon Research Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum.
Read full news articleRubicon Research Ltd Hits All-Time High of Rs 1,238.5 as Momentum Builds Across Timeframes
2026-06-02 09:36:50Extending its winning streak to three sessions, Rubicon Research Ltd surged 7.32% on 2 Jun 2026 to touch a fresh all-time high of Rs 1,238.5, significantly outpacing the Sensex which declined 0.33% on the same day.
Read full news articleRubicon Research Ltd Upgraded to Excellent Quality Grade on Strong Financial Fundamentals
2026-06-02 08:01:17Rubicon Research Ltd has recently been upgraded to an 'excellent' quality grade by MarketsMOJO, reflecting significant improvements in its business fundamentals. This upgrade, effective from 1 June 2026, highlights the company’s robust return metrics, prudent debt management, and consistent operational performance, positioning it favourably within the Pharmaceuticals & Biotechnology sector.
Read full news articleRubicon Research Q4 FY26: Stellar Growth Momentum Drives 112% Profit Surge
2026-06-01 19:19:39Rubicon Research Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹18,586 crores, reported exceptional fourth-quarter results for FY26, with net profit surging 111.83% year-on-year to ₹76.79 crores. The strong performance, driven by robust revenue growth of 43.49% YoY to ₹513.92 crores, sent the stock soaring 16.24% on June 01, 2026, closing at ₹1,167.05 and nearly touching its 52-week high of ₹1,204.80.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
02-Jun-2026 | Source : BSEEarning Call Transcript
Earnings Call Audio Recording
30-May-2026 | Source : BSEEarnings Call Audio Recording
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSERubicon Newspaper Publication under reg 30
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






